GDF15 is required for cold-induced thermogenesis and contributes to improved systemic metabolic health following loss of OPA1 in brown adipocytes
- PMID: 37819027
- PMCID: PMC10567111
- DOI: 10.7554/eLife.86452
GDF15 is required for cold-induced thermogenesis and contributes to improved systemic metabolic health following loss of OPA1 in brown adipocytes
Abstract
We previously reported that mice lacking the protein optic atrophy 1 (OPA1 BKO) in brown adipose tissue (BAT) display induction of the activating transcription factor 4 (ATF4), which promotes fibroblast growth factor 21 (FGF21) secretion as a batokine. FGF21 increases metabolic rates under baseline conditions but is dispensable for the resistance to diet-induced obesity (DIO) reported in OPA1 BKO mice (Pereira et al., 2021). To determine alternative mediators of this phenotype, we performed transcriptome analysis, which revealed increased levels of growth differentiation factor 15 (GDF15), along with increased protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) levels in BAT. To investigate whether ATF4 induction was mediated by PERK and evaluate the contribution of GDF15 to the resistance to DIO, we selectively deleted PERK or GDF15 in OPA1 BKO mice. Mice with reduced OPA1 and PERK levels in BAT had preserved ISR activation. Importantly, simultaneous deletion of OPA1 and GDF15 partially reversed the resistance to DIO and abrogated the improvements in glucose tolerance. Furthermore, GDF15 was required to improve cold-induced thermogenesis in OPA1 BKO mice. Taken together, our data indicate that PERK is dispensable to induce the ISR, but GDF15 contributes to the resistance to DIO, and is required for glucose homeostasis and thermoregulation in OPA1 BKO mice by increasing energy expenditure.
Keywords: GDF15; PERK; biochemistry; brown adipose tissue; chemical biology; integrated stress response; mitochondrial stress; mouse.
© 2023, Jena, García-Peña et al.
Conflict of interest statement
JJ, LG, EW, AM, SB, KK, JK, JC, EA, RP No competing interests declared, RS R.J.S. has received research support from Fractyl, Novo Nordisk, AstraZeneca, and Eli Lilly. R.J.S. has served on scientific advisory boards for Novo Nordisk, CinRX, Scohia, Fractyl and Structure Therapeutics. R.J.S. is a stakeholder of Calibrate and Rewind
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig1.gif)
![Figure 1—figure supplement 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig1-figsupp1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig2.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig3.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig4.gif)
![Figure 4—figure supplement 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig4-figsupp1.gif)
![Figure 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig5.gif)
![Figure 5—figure supplement 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig5-figsupp1.gif)
![Figure 5—figure supplement 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig5-figsupp2.gif)
![Figure 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig6.gif)
![Figure 6—figure supplement 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig6-figsupp1.gif)
![Figure 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig7.gif)
![Figure 7—figure supplement 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10567111/bin/elife-86452-fig7-figsupp1.gif)
Update of
- doi: 10.1101/2022.12.23.521796
Similar articles
-
OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21.Elife. 2021 May 4;10:e66519. doi: 10.7554/eLife.66519. Elife. 2021. PMID: 33944779 Free PMC article.
-
ATF4 expression in thermogenic adipocytes is required for cold-induced thermogenesis in mice via FGF21-independent mechanisms.Sci Rep. 2024 Jan 18;14(1):1563. doi: 10.1038/s41598-024-52004-8. Sci Rep. 2024. PMID: 38238383 Free PMC article.
-
Exploring the In Vivo Role of the Mitochondrial Calcium Uniporter in Brown Fat Bioenergetics.Cell Rep. 2019 Apr 30;27(5):1364-1375.e5. doi: 10.1016/j.celrep.2019.04.013. Cell Rep. 2019. PMID: 31042465 Free PMC article.
-
The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response.Front Endocrinol (Lausanne). 2023 Sep 25;14:1264530. doi: 10.3389/fendo.2023.1264530. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37818094 Free PMC article. Review.
-
Stress-induced FGF21 and GDF15 in obesity and obesity resistance.Trends Endocrinol Metab. 2021 Nov;32(11):904-915. doi: 10.1016/j.tem.2021.08.008. Epub 2021 Sep 13. Trends Endocrinol Metab. 2021. PMID: 34526227 Review.
Cited by
-
A Narrative Review on Adipose Tissue and Overtraining: Shedding Light on the Interplay among Adipokines, Exercise and Overtraining.Int J Mol Sci. 2024 Apr 6;25(7):4089. doi: 10.3390/ijms25074089. Int J Mol Sci. 2024. PMID: 38612899 Free PMC article. Review.
-
DELE1 promotes translation-associated homeostasis, growth, and survival in mitochondrial myopathy.bioRxiv [Preprint]. 2024 Feb 29:2024.02.29.582673. doi: 10.1101/2024.02.29.582673. bioRxiv. 2024. PMID: 38529505 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources